Needham & Company LLC Reaffirms “Hold” Rating for ICU Medical (NASDAQ:ICUI)

Needham & Company LLC reiterated their hold rating on shares of ICU Medical (NASDAQ:ICUI) in a report issued on Tuesday morning,Benzinga reports.

Several other analysts have also recently weighed in on ICUI. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday, April 4th. Raymond James set a $97.00 price target on ICU Medical in a report on Wednesday, March 12th. Finally, Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective on the stock in a research note on Wednesday, December 11th. One analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, ICU Medical has an average rating of “Buy” and an average target price of $168.67.

ICU Medical Stock Down 8.3 %

Shares of NASDAQ:ICUI opened at $138.43 on Tuesday. The company’s fifty day moving average is $148.66 and its 200-day moving average is $161.17. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical has a 52 week low of $93.36 and a 52 week high of $196.26. The company has a market capitalization of $3.39 billion, a PE ratio of -30.29 and a beta of 0.86.

Institutional Trading of ICU Medical

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Harvest Fund Management Co. Ltd bought a new position in ICU Medical in the 4th quarter valued at $33,000. Quarry LP lifted its stake in shares of ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier’s stock valued at $38,000 after acquiring an additional 214 shares during the period. Murphy & Mullick Capital Management Corp bought a new position in ICU Medical in the fourth quarter valued at about $52,000. Venturi Wealth Management LLC boosted its holdings in ICU Medical by 64.0% in the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier’s stock valued at $82,000 after acquiring an additional 206 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its position in ICU Medical by 88.8% in the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier’s stock worth $99,000 after purchasing an additional 300 shares during the period. Institutional investors and hedge funds own 96.10% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.